EHMD Clinical Benefits
Together, we can reduce the risk of...
with clinically proven human milk–based nutritional products
Learn MoreOvercoming the complications of prematurity
Recent studies have examined the impact of Prolacta’s products as part of an exclusive human milk diet (EHMD) on reducing common comorbidities associated with prematurity:
The findings of multiple studies indicate that premature infants fed Prolacta’s fortifiers as part of an EHMD have a lower incidence of these complications, compared with infants fed cow milk–based fortifiers.
Overcoming necrotizing enterocolitis
A combined analysis of two randomized clinical studies demonstrates a dose–response relationship that negatively affects patient outcomes. For every 10% increase in the volume of milk containing cow milk–based protein, the risk of NEC increased by 11.8%, surgical NEC by 21%, and sepsis by 17.9%.5
How to bring Prolacta products into your NICU
- Identify desired clinical outcomes, such as reducing the incidence of BPD, as well as anticipated economic outcomes
- Consult with us to determine the optimal feeding protocol, as well as possibilities for coding, billing, and reimbursement for Prolacta products
- Prepare your facility with implementation, staff training, and parent education